Prof G Markets: Google’s Antitrust Trial, Birkenstock’s IPO, and Surge Pricing at the Pub

Prof G Markets: Google’s Antitrust Trial, Bir...

Up next

No Mercy / No Malice: I Disagree

Audio excerpted with permission of Penguin Random House Audio from I DISAGREE by Jessica Tarlov, read by the author. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

The Week: The Right Turns Against the Rich

George Hahn connects the dots across the week’s biggest stories: why California may impose a one-time tax on billionaire wealth, how Tucker Carlson could pair right-wing culture with populist economics, and why China’s decades-long infrastructure strategy may give it an advantage ...  Show more

Recommended Episodes

Breaking Down the Google Monopoly Ruling — ft. Rebecca Allensworth
Prof G Markets

Scott and Ed open the show by discussing Airbnb, Disney, and Shopify’s latest earnings, as well as X’s lawsuit against advertisers. Then they speak with Professor Rebecca Allensworth, Associate Dean for Research at Vanderbilt University, about the Google antitrust case. She break ...  Show more

Is Google a Buy? + Is Uber Recession Proof?
Prof G Markets

Scott and Ed discuss Trump’s new trade framework with the U.K., the Federal Reserve’s latest decision, and the Melania coin grift. Then they take a look at Apple’s potential move to replace Google as Safari’s default search engine, unpacking the ripple effects on Google’s stock. ...  Show more

OpenAI’s Exodus, the Rise of Palantir, and the Longshoremen’s Strike
Prof G Markets

Scott and Ed open the show by discussing the DOJ’s antitrust lawsuit against Visa, Meta’s new AR glasses and the recent executive resignations at OpenAI. Then Scott explains why Palantir is one of the most overvalued companies in tech, and why he thinks the brand has resonated wi ...  Show more

Meta’s AI Promise, Microsoft’s Disappointing Beat & Why Google Should Spin Youtube
Prof G Markets

Scott and Ed open the show by discussing the U.S.’s GDP growth, Reddit’s earnings, Eli Lilly’s third quarter drug sales, and xAI’s new funding round. Then Scott and Ed break down big tech’s earnings and discuss how the tech companies are using capital as a weapon. They also exami ...  Show more